NCOA4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.938100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.320000E-01
Normal-vs-Stage2
1.028820E-01
Normal-vs-Stage3
1.626000E-02
Normal-vs-Stage4
7.263400E-01
Stage1-vs-Stage2
7.436400E-01
Stage1-vs-Stage3
1.502400E-01
Stage1-vs-Stage4
4.510600E-01
Stage2-vs-Stage3
1.967830E-01
Stage2-vs-Stage4
1.966360E-01
Stage3-vs-Stage4
8.000200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.129700E-02
Normal-vs-AfricanAmerican
9.378400E-01
Normal-vs-Asian
4.595800E-02
Caucasian-vs-AfricanAmerican
1.697590E-01
Caucasian-vs-Asian
2.355600E-01
AfricanAmerican-vs-Asian
3.720000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.008500E-02
Normal-vs-Female
1.122640E-01
Male-vs-Female
6.752000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.257900E-02
Normal-vs-Age(41-60Yrs)
3.052800E-01
Normal-vs-Age(61-80Yrs)
4.251700E-02
Normal-vs-Age(81-100Yrs)
2.735500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.682800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.362400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.445600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.923400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.793640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.695000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.727550E-02
Normal-vs-Daily Drinker
1.361980E-02
Normal-vs-Weekly Drinker
7.458000E-02
Normal-vs-Occasional Drinker
2.117200E-01
Normal-vs-Social Drinker
1.204590E-01
Non Drinker-vs-Daily Drinker
6.051600E-01
Non Drinker-vs-Weekly Drinker
8.967400E-01
Non Drinker-vs-Occasional Drinker
1.147430E-01
Non Drinker-vs-Social Drinker
4.732800E-01
Daily Drinker-vs-Weekly Drinker
6.123200E-01
Daily Drinker-vs-Occasional Drinker
6.618500E-02
Daily Drinker-vs-Social Drinker
2.945600E-01
Weekly Drinker-vs-Occasional Drinker
2.839800E-01
Weekly Drinker-vs-Social Drinker
6.623400E-01
Occasional Drinker-vs-Social Drinker
5.271600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.393980E-01
Normal-vs-Grade 2
4.023800E-02
Normal-vs-Grade 3
3.116300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.474300E-02
Grade 1-vs-Grade 3
1.868180E-01
Grade 1-vs-Grade 4
1.393980E-01
Grade 2-vs-Grade 3
6.010000E-01
Grade 2-vs-Grade 4
4.023800E-02
Grade 3-vs-Grade 4
3.116300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.442200E-02
Normal-vs-NonDiabetic
4.264300E-02
Diabetic-vs-NonDiabetic
9.910000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.675900E-03
Normal-vs-NoPancreatitis
5.898200E-02
Pancreatitis-vs-NoPancreatitis
4.002000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.832400E-02
Normal-vs-N1
1.007030E-01
N0-vs-N1
6.158800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.306020E-01
Normal-vs-TP53-NonMutant
2.956200E-01
TP53-Mutant-vs-TP53-NonMutant
5.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
